A
Anu
About Anu
Data last updated:
Anu is a Director at Lxora Lifesciences Private Limited (since 2024), Additional Director at Hazecure Pharma Private Limited (since 2025) and Director at Ainsley Lifesciences Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Food And Beverages and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹6.09 Cr; the largest is Lxora Lifesciences Private Limited at ₹5.79 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Mar 2024 | 2022 | ₹5.79 Cr (FY 2025) | Active | |
| Additional Director | 14 Apr 2025 | 2022 | ₹29.8 Lakh (FY 2024) | Active | |
| Director | 07 Apr 2025 | 2021 | ₹49,443 (FY 2025) | Active | |
| Director | 10 Jul 2026 | 2026 | Active |
Board colleagues of Anu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sanjeev Kumar | 06839990 | Lxora Lifesciences Private Limited , Ainsley Lifesciences Private Limited and 1 more | Managing Director |
| Dhruv Mehta | 09670483 | Hazecure Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anu
Anu currently holds 4 directorships: Lxora Lifesciences Private Limited (Director, since 28 Mar 2024, revenue ₹5.79 Cr (FY 2025)); Hazecure Pharma Private Limited (Additional Director, since 14 Apr 2025, revenue ₹29.8 Lakh (FY 2024)); Ainsley Lifesciences Private Limited (Director, since 07 Apr 2025, revenue ₹49,443 (FY 2025)); Indisun Lifesciences Private Limited (Director, since 10 Jul 2026).
Anu was first appointed on 28 Mar 2024 as Director at Lxora Lifesciences Private Limited. The most recent appointment on record is 10 Jul 2026 at Indisun Lifesciences Private Limited.
The 3 current companies of Anu that report revenue have a combined latest revenue of ₹6.09 Cr: Lxora Lifesciences Private Limited ₹5.79 Cr (FY 2025); Hazecure Pharma Private Limited ₹29.8 Lakh (FY 2024); Ainsley Lifesciences Private Limited ₹49,443 (FY 2025).
The current boards of Anu's companies include Sanjeev Kumar (Lxora Lifesciences Private Limited), Dhruv Mehta (Hazecure Pharma Private Limited).